|
||||||||
|
||||||||
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||
Provisional data concerning the reported occurrence of notifiable diseases are published weekly in MMWR. After each reporting year, staff in state health departments finalize reports of cases for that year with local or county health departments and reconcile the data with reports previously sent to CDC throughout the year; these data are compiled in final form in this summary. Notifiable disease reports (which are published in the annual MMWR Summary of Notifiable Diseases only after approval by the appropriate epidemiologist from each submitting state or territory) are the authoritative and archival counts of cases. Data published in MMWR Surveillance Summaries or other surveillance reports produced by CDC programs, which are useful for detailed epidemiologic analyses, may not agree exactly with data reported in the annual Summary of Notifiable Diseases because of differences in the timing of reports, the source of the data, and the use of different case definitions.
Data in this summary were derived primarily from reports transmitted to the Division of Public Health Surveillance and Informatics, Epidemiology Program Office, CDC, by the 50 state, two city, and five territorial health departments through the National Electronic Telecommunications System for Surveillance (NETSS). (For more information regarding NETSS and notifiable diseases, including case definitions for these conditions, see World-Wide Web site http://www.cdc.gov/epo/phs.htm). Final data for other diseases are from the surveillance-program records of the following CDC programs (requests for further information regarding these data should be directed to the source specified):
National Center for Health Statistics (NCHS) Office
of Vital and Health Statistics Systems (deaths from selected notifiable
diseases)
National Center for Infectious Diseases (NCID) Division
of Bacterial and Mycotic Diseases (toxic-shock syndrome and laboratory
data regarding botulism, Escherichia coli O157:H7, Salmonella,
and Shigella)
Division of Vector-Borne Infectious Diseases (laboratory data regarding arboviral
encephalitis)
Division of Viral and Rickettsial Diseases (animal rabies)
National Center for HIV, STD, and TB Prevention (NCHSTP) Division
of HIV/AIDS Prevention, Surveillance and Epidemiology (acquired immunodeficiency
syndrome (AIDS))
Division of Sexually Transmitted Diseases Prevention (chancroid, chlamydia,
gonorrhea, and syphilis)
Division of Tuberculosis Elimination (tuberculosis)
National Immunization Program (NIP) Epidemiology and Surveillance
Division (poliomyelitis)
Disease totals for the United States, unless otherwise stated, do not include data for American Samoa, Guam, Puerto Rico, the Virgin Islands, and the Commonwealth of the Northern Mariana Islands (CNMI). Disease totals from American Samoa were unavailable for 1996.
Population estimates for states are based on the July 1, 1996, post-censal estimates made by the U.S. Department of Commerce, Bureau of the Census, Population Division, Population Estimates Branch, PPL-57. Because these estimates are unavailable by age and sex for 1996, rates for reported disease occurrences by age group and among males and females use population totals from the 1995 post-censal estimates. Population estimates for territories are from the 1990 census, U.S. Department of Commerce, Bureau of the Census, Press Releases CB91-142, 242, 243, 263, and 276.
Rates in the 1996 Summary of Notifiable Diseases were based on data for the U.S. total-resident population. However, population data from states in which diseases were not notifiable or disease data were not available were excluded from rate calculations.
Privacy Policy | Accessibility CDC Home | Search | Health Topics A-Z This page last updated January 9, 2008 United States
Department of Health and Human Services "Epi Info" is a trademark of the Centers for Disease Control and Prevention (CDC). |